CLINICAL EVENTS CALENDAR
Non-Accredited Education

CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Issue
- Issue Number:4
Introduction
Guidewires are a fundamental component of any cardiac and vascular interventional procedure. These interventions may include coronary angioplasty, carotid stenting, endovascular aortic aneurysm repair (EVAR), superficial femoral artery (SFA) stenting, and inferior vena cava (IVC) filter placement. Numerous options exist for the guidewire available to interventionalists and surgeons. These guidewires vary in design and physical properties, and thus are not identical in their capabilities. While there have been evaluations of individual guidewires,1–9
- Issue Number:4
Carotid artery stenting (CAS) has variably fallen in and out of favor. Some have argued that CAS should be reserved for those patients who are at highest risk, not only for endartectomy (CEA), but if only treated medically. Unfortunately, none of the current trials or registries has been adequately designed to allow for equal comparison between the three treatment strategies — surgery, stenting, and medical therapy. Recent randomized trials comparing CAS and CEA contain significant methodological flaws and are thus inadequate for definitive comparisons, though they are thought provoking
- Issue Number:4
The popliteal artery aneurysm is the most common peripheral aneurysm, accounting for 70–80%. It is found mainly in male patients,10-12 with 50% of all cases being bilateral.13 The pathogenesis is often atherosclerotic, however, generalized dilatation and elongation of other arteries, such as the abdominal aorta, suggest a systemic abnormality.14 Mechanical stresses like hypertension, which is present in many patients15,16 and the fixation of the vessel at the adductor hiatus can contribute to aneurysm formation in the popliteal artery. Non-
- Issue Number:4
Introduction
- Issue Number:4
Introduction
The number of percutaneous revascularization procedures performed for symptomatic peripheral arterial disease (PAD) has significantly increased over the past several years.1 Traditionally, the use of percutaneous techniques were limited to certain anatomic subsets, such as stenosis or focal occlusions, with surgical treatment preferred for more extensive disease.2 More recently, endovascular specialists are facing the challenges of treating commonly- encountered peripheral chronic total occlusions (CTOs). Furthermore, unlike the co
- Percutaneous Revascularization of Peripheral Chronic Total Occlusion — Which Patients, Why, and How?Issue Number:4
Recanalization of peripheral arterial total occlusion in lower extremities plays a pivotal role to improve claudication symptoms and limb salvage. Coronary chronic total occlusion (CTO) recanalization has recently gathered controversy with the publication of the occluded artery trial (OAT). However, in peripheral vasculature, specifically in the superficial femoral artery (SFA), occlusion predominates stenosis. The predominance of occlusion is due to limited collaterals, namely the profunda femoris artery and the diffuse nature of the disease.2 The constant endothelial injury, d
- Issue Number:4
The idea for this editorial emerged in my mind while reviewing the article “A Comparison of Interventional Guidewires in a Canine Model” by Huang et al. The authors set out to test three different wires in the setting of an in vivo experiment. They used some of the most common maneuvers interventionists perform with guidewires in the course of endovascular procedures. Not surprisingly, the study showed the superiority of the GlideWire. I thought it was reassuring — at least to me!
And now the rest of the story; and it’s all personal. As a vascular surgeon da
- Issue Number:4
Introduction
The risk of embolization during CAS may be influe
Using Advanced Technology to
Treat Occluded Below-the-Knee Arteries
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.Superior Mesenteric Artery Revascularization and
Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.Vascular Disease News Wire
- Thursday, December 11, 2008 - 16:23
- Monday, November 24, 2008 - 11:56
- Monday, October 6, 2008 - 10:02
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast
Release Date: December 22, 2008
Expiration Date: December 22, 2009
This activity is supported by an educational grant from PamLabs.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).To register for this Webcast, visit www.naccme.com/program/n-558/

LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI
Live Symposium
Date: February 26-28
Location: Loews Miami Beach Hotel
Miami Beach, Florida 33139
Phone: (305) 604-1601
Toll Free: 1-877-563-9762
This activity is sponsored by the North American Center for Continuing Medical Education.
CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence
A Complimentary CME Accredited Lunch Symposium
Date: Friday, September 12, 2008
12:00 pm - 1:15 pm
Location: Hynes Convention Center
900 Boylston Street, Room 304
Boston, MA 02115This activity is supported by an educational grant from Bracco Diagnostics Inc.







